Reframing the Debate over Performance-Enhancing Drugs: The Reasonable Athlete Argument

被引:0
|
作者
Altman, Matthew C. [1 ]
机构
[1] Cent Washington Univ, Dept Philosophy & Comparat Relig, 400 E Univ Way, Ellensburg, WA 98926 USA
关键词
Performance-enhancing drugs; doping; fairness; coercion; steroids; SPORT; HEALTH;
D O I
10.1080/17511321.2023.2266581
中图分类号
B82 [伦理学(道德学)];
学科分类号
摘要
Two of the major arguments against performance-enhancing drugs (PEDs), appealing to fairness and the protection of athletes' health, have serious flaws. First, there is no relevant moral distinction between the use of PEDs and the use of other performance enhancers that introduce unfairness and that we accept nonetheless. Second, prohibiting PEDs for athletes' own good ignores the fact that adult athletes are constantly making tradeoffs to improve performance and pursue excellence, including sacrificing their health. We should not paternalistically impose our values on them. On the other side, arguments to allow 'safe' PEDs provide no normative criterion to determine the acceptable level of risk, thus begging the question. The reasonable athlete argument solves both sets of problems: it justifies a ban on some performance-enhancing drugs based on health and fairness, while avoiding paternalism, and it also establishes a non-arbitrary standard to determine which drugs ought to be allowed. First, if unsafe PEDs were allowed, some athletes would refuse to take them out of concern for their health. This is a reasonable decision even though it would put them at a competitive disadvantage against athletes who choose to use unsafe PEDs. It would be unfair for clean athletes to suffer a competitive disadvantage for acting reasonably. Therefore, PEDs that pose significant health risks should be prohibited for all athletes. Second, it would be unreasonable for athletes to refuse, on principle, relatively safe and effective PEDs, so a blanket prohibition is also unjustified. Which drugs and which doses to allow should be determined not by athletes' actual choices but by the hypothetical choices of the reasonable athlete. The resulting sport-specific drug policy would carve a justifiable middle path between complete prohibition and complete permission.
引用
收藏
页数:14
相关论文
共 50 条
  • [21] Cardiovascular Effects of Performance-Enhancing Drugs
    La Gerche, Andre
    Brosnan, Maria J.
    CIRCULATION, 2017, 135 (01) : 89 - 99
  • [22] Sports medicine: Performance-enhancing drugs
    Gregory, Andrew J. M.
    Fitch, Robert W.
    PEDIATRIC CLINICS OF NORTH AMERICA, 2007, 54 (04) : 797 - +
  • [23] Performance-Enhancing Drugs: Understanding the Risks
    Hatton, Caroline K.
    Green, Gary A.
    Ambrose, Peter J.
    PHYSICAL MEDICINE AND REHABILITATION CLINICS OF NORTH AMERICA, 2014, 25 (04) : 897 - +
  • [24] PROPOSED TIGHTER CONTROL ON PERFORMANCE-ENHANCING DRUGS
    REED, GA
    AUSTRALIAN VETERINARY JOURNAL, 1989, 66 (07) : A217 - A217
  • [25] Rorty, performance-enhancing drugs, and change in sport
    Dixon, N
    JOURNAL OF THE PHILOSOPHY OF SPORT, 2001, 28 (01) : 78 - 88
  • [26] Raising awareness about performance-enhancing drugs
    Scott, George C.
    JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2008, 233 (03): : 383 - 383
  • [27] Performance-enhancing drugs as a collective action problem
    Russell, J. S.
    Browne, Alister
    JOURNAL OF THE PHILOSOPHY OF SPORT, 2018, 45 (02) : 109 - 127
  • [28] Use of 'performance-enhancing' drugs by general practitioners
    Laure, P
    Binsinger, C
    THERAPIE, 2003, 58 (05): : 445 - 450
  • [29] Performance-Enhancing Drugs and Moral Line Drawing
    Sailors, Pam R.
    AMERICAN JOURNAL OF BIOETHICS, 2018, 18 (06): : 16 - 17
  • [30] Performance-enhancing drugs snare nonathletes, too
    Mitzi, Marifel
    Fernandez, F.
    Hosey, Robert G.
    JOURNAL OF FAMILY PRACTICE, 2009, 58 (01): : 16 - 23